[go: up one dir, main page]

DK2844344T3 - Behandling af inflammatoriske tilstande og forbedring af mundhygiejne ved hjælp af metalmodulatorer med methylsulfonylmethan som transportforbedrer - Google Patents

Behandling af inflammatoriske tilstande og forbedring af mundhygiejne ved hjælp af metalmodulatorer med methylsulfonylmethan som transportforbedrer Download PDF

Info

Publication number
DK2844344T3
DK2844344T3 DK13784151.6T DK13784151T DK2844344T3 DK 2844344 T3 DK2844344 T3 DK 2844344T3 DK 13784151 T DK13784151 T DK 13784151T DK 2844344 T3 DK2844344 T3 DK 2844344T3
Authority
DK
Denmark
Prior art keywords
methylsulfonylmethane
modulators
improvement
treatment
metal
Prior art date
Application number
DK13784151.6T
Other languages
English (en)
Inventor
Rajiv Bhushan
Jerry B Gin
Amit Goswamy
Original Assignee
Rajiv Bhushan
Jerry B Gin
Amit Goswamy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rajiv Bhushan, Jerry B Gin, Amit Goswamy filed Critical Rajiv Bhushan
Application granted granted Critical
Publication of DK2844344T3 publication Critical patent/DK2844344T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/46—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing sulfur
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/44—Aminocarboxylic acids or derivatives thereof, e.g. aminocarboxylic acids containing sulfur; Salts; Esters or N-acylated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0063—Periodont
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/02—Local antiseptics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/51—Chelating agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Birds (AREA)
  • Diabetes (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Endocrinology (AREA)
  • AIDS & HIV (AREA)
  • Rheumatology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK13784151.6T 2012-05-03 2013-05-03 Behandling af inflammatoriske tilstande og forbedring af mundhygiejne ved hjælp af metalmodulatorer med methylsulfonylmethan som transportforbedrer DK2844344T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261642441P 2012-05-03 2012-05-03
PCT/US2013/039573 WO2013166459A1 (en) 2012-05-03 2013-05-03 Treating inflammatory conditions and improving oral hygiene using metal modulators with methylsulfonylmethane as transport enhancer

Publications (1)

Publication Number Publication Date
DK2844344T3 true DK2844344T3 (da) 2021-04-19

Family

ID=49514928

Family Applications (1)

Application Number Title Priority Date Filing Date
DK13784151.6T DK2844344T3 (da) 2012-05-03 2013-05-03 Behandling af inflammatoriske tilstande og forbedring af mundhygiejne ved hjælp af metalmodulatorer med methylsulfonylmethan som transportforbedrer

Country Status (11)

Country Link
US (1) US20150132347A1 (da)
EP (1) EP2844344B1 (da)
JP (3) JP6315615B2 (da)
AU (3) AU2013256039A1 (da)
DK (1) DK2844344T3 (da)
ES (1) ES2859682T3 (da)
IL (1) IL235480A0 (da)
IN (1) IN2014DN10291A (da)
PT (1) PT2844344T (da)
RU (1) RU2014148805A (da)
WO (1) WO2013166459A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2694758C2 (ru) * 2012-12-20 2019-07-16 Раджив Бхушан Антимикробные композиции
WO2014100775A1 (en) * 2012-12-20 2014-06-26 Rajiv Bhushan Anti-plaque oral compositions
RU2601905C1 (ru) * 2015-06-26 2016-11-10 Федеральное государственное автономное образовательное учреждение высшего профессионального образования "Северо-Восточный федеральный университет имени М.К.Аммосова" Способ лечения гингивита
DE102016101280A1 (de) 2016-01-26 2017-07-27 Frank Bröseler Pharmazeutische Zusammensetzung
WO2017195135A1 (en) * 2016-05-11 2017-11-16 Nestec Sa Compositions and methods for reducing or preventing dental calculus accumulation in companion animals
CA3057468A1 (en) * 2017-03-21 2018-09-27 Gr Biosystems, Inc. Compositions for treating periodontal diseases
WO2019053260A2 (en) * 2017-09-15 2019-03-21 Nobel Biocare Services Ag COMPOSITIONS AND FILMS FOR APPLICATION TO DENTAL SUBSTRATES
CN110194996A (zh) * 2019-07-03 2019-09-03 韶关学院 一种食源性细菌生物被膜清除剂及其应用

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI75734C (fi) * 1984-12-18 1988-08-08 Lilius Kaj Rainer Munskoeljningsloesning.
US4670252A (en) * 1985-05-24 1987-06-02 The Procter & Gamble Company Treatment of oral diseases
JPH06321743A (ja) * 1993-05-19 1994-11-22 Sankyo Co Ltd 口腔洗浄剤
CA2184316A1 (en) * 1995-09-12 1997-03-13 Wei-Chi Liao Buccal delivery system for therapeutic agents
US6265444B1 (en) 1997-05-23 2001-07-24 Insite Vision Incorporated Ophthalmic composition
US6017516A (en) * 1997-10-31 2000-01-25 Lekar Pharma Limited Pharmaceutical dental formulation for topical application of metronidazole benzoate and chlorhexidine gluconate
US6228347B1 (en) * 1997-12-01 2001-05-08 Thione International, Inc. Antioxidant gel for gingival conditions
EP1124582B1 (en) 1998-10-27 2003-12-10 Alcon Laboratories, Inc. Preservative system for topically administrable pharmaceutical compositions
US6348508B1 (en) 2000-04-04 2002-02-19 Bausch & Lomb Incorporated Method for treating dry eye
US20060034782A1 (en) * 2001-12-04 2006-02-16 Brown Dale G Biofilm therapy interproximal devices
US6645472B1 (en) * 2002-09-13 2003-11-11 Michael R. Anderson Oral hygiene powder composition and method
NZ540885A (en) * 2002-12-20 2009-02-28 Chakshu Res Inc Ophthalmic formulation for the prevention and treatment of ocular conditions
ITMI20030195A1 (it) * 2003-02-06 2004-08-07 Bsd Bioscience Dev Snc Di O Mini C E Zucc Formulazioni topiche contenenti principi attivi naturali adatte alla prevenzione e cura dei processi infiammatori delle mucose
US20040158194A1 (en) * 2003-02-06 2004-08-12 Wolff Andy And Beiski Ben Z. Oral devices and methods for controlled drug release
US20060083727A1 (en) * 2004-07-15 2006-04-20 Nanobac Pharmaceuticals, Inc. Methods and compositions for the treatment of diseases characterized by calcification and/or plaque formation
JP2006182705A (ja) * 2004-12-28 2006-07-13 Lion Corp 歯牙貼付用製品及び口腔ケア物質の供給方法
US20060198795A1 (en) * 2005-11-07 2006-09-07 Giniger Martin S Multi-component oral care compositions
WO2007011874A2 (en) * 2005-07-15 2007-01-25 Chakshu Research Inc. Formulation and method for administration of ophthalmologically active agents
US20080038219A1 (en) * 2006-08-07 2008-02-14 Calgenex Corporation Novel Composition for a Topical Skin Treatment Base and Medicated Applications Thereof
BRPI0807943A2 (pt) * 2007-02-15 2014-10-21 Derma Young Ltd Composição farmacêutica ou nutracêutica e métodos para melhorar a administração de um ingrediente farmacêutico pela mucosa oral e para supressão de apetite
US7850453B2 (en) * 2007-08-08 2010-12-14 Coll Partners Ltd. Reshapable device for fixation at a dental site
WO2009114650A1 (en) * 2008-03-11 2009-09-17 Chakshu Research, Inc. Methods and compositions for treating inflammation and inflammation-related pathologies
JP5467800B2 (ja) * 2009-05-14 2014-04-09 ロート製薬株式会社 唾液分泌促進剤及び唾液分泌促進用組成物
US8434489B2 (en) * 2009-10-23 2013-05-07 Conceptus, Inc. Contraceptive devices and methods

Also Published As

Publication number Publication date
EP2844344A4 (en) 2016-03-09
ES2859682T3 (es) 2021-10-04
EP2844344B1 (en) 2021-01-13
IN2014DN10291A (da) 2015-08-07
EP2844344A1 (en) 2015-03-11
AU2020204162B2 (en) 2023-08-03
JP2018052971A (ja) 2018-04-05
PT2844344T (pt) 2021-04-06
JP2015515991A (ja) 2015-06-04
AU2013256039A1 (en) 2015-01-15
IL235480A0 (en) 2014-12-31
AU2018204291A1 (en) 2018-07-05
RU2014148805A (ru) 2016-06-20
JP6315615B2 (ja) 2018-04-25
AU2020204162A1 (en) 2020-07-09
WO2013166459A1 (en) 2013-11-07
JP2019206572A (ja) 2019-12-05
US20150132347A1 (en) 2015-05-14

Similar Documents

Publication Publication Date Title
DK2844344T3 (da) Behandling af inflammatoriske tilstande og forbedring af mundhygiejne ved hjælp af metalmodulatorer med methylsulfonylmethan som transportforbedrer
DK2898061T3 (da) Probiotiske sammensætninger til behandlingen af fedme og fedme-relaterede tilstande
DK2688557T3 (da) Fremgangsmåder og sammensætninger til behandling af forstyrelse af opmærksomhed
DK2723347T3 (da) Forebyggelse og behandling af inflammationstilstande
DK3295942T3 (da) Kombinationer omfattende 5-phenoxy-3h-pyrimidin-4-on-derivater og anvendelse heraf til profylakse eller behandling af hiv-infektion
DK2861584T3 (da) Pyridopyrazin- og naphthyridinderivater til behandling af cancer
DK2776567T3 (da) Sammensætninger og fremgangsmåder til behandling af cytomegalovirus.
DK2895621T3 (da) Fremgangsmåder og sammensætning til diagnosticering, prognose og behandling af neurologiske tilstande
DK3378862T3 (da) Dihydropyrimidinoisoquinolinoner og farmaceutiske sammensætninger deraf til behandlingen af multipel sklerose
DK2763665T3 (da) Antimikrobielle sammensætninger og fremgangsmåder til anvendelse deraf
HUE038759T2 (hu) Terápiás nukleázkészítmények és eljárások
DK2882441T3 (da) Behandling af immunrelaterede og inflammatoriske sygdomme
DK3415157T3 (da) N-acyldipeptidderivater og anvendelser deraf
BR112014006291A2 (pt) composição e utilização da composição
PL2830654T3 (pl) Sposoby i kompozycje do leczenia zapalenia
BR112013014644A2 (pt) composição farmacêutica e complexo
FI20135146L (fi) Farmaseuttiset koostumukset ja hoitomenetelmät
DK2646452T3 (da) Chlorering af carbohydrater og carbohydratderivater
DK3392252T3 (da) Pyrimido-pyridazinonforbindelser og deres anvendelse
DK2661274T3 (da) Sammensætninger og fremgangsmåder med aloepolysaccharider
DK2854910T3 (da) Ceramidniveauer i behandling og forebyggelse af infektioner
DK2688588T3 (da) Hurtig- og langtidsvirkende immunologisk terapeutisk middel
DK3156060T3 (da) Farmaceutiske sammensætninger og topisk anvendelse deraf
EP2753337A4 (en) COMPOSITIONS COMPRISING BETA-GLUCANS AND METHODS OF USE
DK2892556T3 (da) Sammensætninger og fremgangsmåder til behandling af sygdomme